BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 16260719)

  • 1. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
    Araki O; Ying H; Furuya F; Zhu X; Cheng SY
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY; Cho IJ; Kim SG
    Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of peroxisome proliferator signaling pathways by thyroid hormone receptor. Competitive binding to the response element.
    Miyamoto T; Kaneko A; Kakizawa T; Yajima H; Kamijo K; Sekine R; Hiramatsu K; Nishii Y; Hashimoto T; Hashizume K
    J Biol Chem; 1997 Mar; 272(12):7752-8. PubMed ID: 9065436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes.
    Hunter J; Kassam A; Winrow CJ; Rachubinski RA; Capone JP
    Mol Cell Endocrinol; 1996 Feb; 116(2):213-21. PubMed ID: 8647322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation.
    Monden T; Yamada M; Nihei Y; Kishi M; Tomaru T; Ishii S; Hashida T; Shibusawa N; Hashimoto K; Satoh T; Kasai K; Mori M
    Life Sci; 2004 Dec; 76(7):731-41. PubMed ID: 15581905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway.
    Kato Y; Ying H; Zhao L; Furuya F; Araki O; Willingham MC; Cheng SY
    Oncogene; 2006 May; 25(19):2736-47. PubMed ID: 16314832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis.
    Ying H; Suzuki H; Zhao L; Willingham MC; Meltzer P; Cheng SY
    Cancer Res; 2003 Sep; 63(17):5274-80. PubMed ID: 14500358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator activated receptor-gamma (PPARgamma) represses thyroid hormone signaling in growth plate chondrocytes.
    Wang L; Shao YY; Ballock RT
    Bone; 2005 Sep; 37(3):305-12. PubMed ID: 16023420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene.
    Buroker NE; Barboza J; Huang JY
    FEBS J; 2009 Jun; 276(12):3247-55. PubMed ID: 19438714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
    Lee KC; Li J; Cole PA; Wong J; Kraus WL
    Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
    Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
    Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
    Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
    J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
    Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
    Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peroxisome proliferator-activated receptor gamma-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription.
    Krätzner R; Fröhlich F; Lepler K; Schröder M; Röher K; Dickel C; Tzvetkov MV; Quentin T; Oetjen E; Knepel W
    Mol Pharmacol; 2008 Feb; 73(2):509-17. PubMed ID: 17962386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
    Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
    Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
    Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
    Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
    Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
    Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.